Investigating on pathophysiology of Irritable Bowel Syndrome (IBS) and its associating genetic derangements: A review study

Authors

Abstract:

Introduction: Irritable Bowel Syndrome (IBS) is known as a prevalent, long-term condition of the digestive system, which affect a significant proportion of societies.Methods: In the current study, we have reviewed and investigated on the conducted researches covering IBS pathophysiology and the genes associated  with the manifestation of the syndrome.Findings: Throughout the published literature about IBS, various environmental factors as well as the influence of particular genes have been introduced as the underlying causes of raising IBS. This study is an effort to review, assess and collect data on multiple causes which leads to IBS manifestation.Conclusion: Although no certain and definite cause of IBS was found throughout searched and reviewed articles, factors such as stresses, childhood events, previous bowel infection, neurotransmitter changes in brain and genetic alterations have been described and explained through articles. Diagnosing IBS should be done precautiously and primary examinations on inspecting organic diseases in the digestive system should take place prior to diagnosis of the syndrome  

Upgrade to premium to download articles

Sign up to access the full text

Already have an account?login

similar resources

A review on pathophysiology of irritable bowel syndrome with emphasis on the role of brain factors

Irritable bowel syndrome (IBS) is a common and chronic functional gastrointestinal disorder that causes a great burden on the individual and society. Despite many studies, there is no consent about the etiology, diagnostic and treatment method of IBS. In recent years, neurologic factors have been given attention for better understanding and management of this disorder. The aim of the present st...

full text

Irritable Bowel Syndrome (IBS): Introduction

Irritable Bowel Syndrome (IBS), which is classified as a functional gastrointestinal disorder, is a chronic condition of the lower gastrointestinal tract (Figure 1) that affects as many as 15% of adults in the United States. Not easily characterized by structural abnormalities, infection, or metabolic disturbances, the underlying mechanisms of IBS have for many years remained unclear. Recent re...

full text

Trial on IBS, Irritable Bowel Syndrome

CONDITIONS: Half of the irritable bowel syndrome patients received an exclusion diet that took into account the individual food incompatibilities (detectable by means of a test for food-specific IgG antibodies). The other irritable bowel syndrome patients received a sham diet that did not take into account any incompatibilities. The following symptoms were measured: deterioration and improvemen...

full text

Irritable Bowel Syndrome (IBS) and Diet

The role of diet in patients with Irritable Bowel Syndrome still remains empirical, as the underlying pathophysiologic disturbances of this disorder are not fully elucidated and randomised controlled trials are difficult to perform. The mainstey for dietary manipulation still remains the exclusion diets. The new, in this field is that the “forbidden” foods are fewer than in the past and the die...

full text

Irritable bowel syndrome: current review on pathophysiology and diagnotic aspects.

Until now, Irritable Bowel Syndrome (IBS) has been one of gastrointestinal disorders which have not been fully understood. Clinically, there are some findings that indicate the role of inflammatory process in pathogenesis of IBS; such as, the onset of IBS that occurs after an episode of gastroenteritis (post-infective IBS (PI-IBS)). Although there is less evidence supporting genetic factors in ...

full text

Irritable bowel syndrome: methods, mechanisms, and pathophysiology. Genetic epidemiology and pharmacogenetics in irritable bowel syndrome.

The objectives of this review are twofold. Our first objective is to evaluate the evidence supporting a role for genetics in irritable bowel syndrome (IBS). Specific examples of the associations of genetic variation and symptoms, syndromes, and intermediate phenotypes, including neurotransmitter (serotonergic, α(2)-adrenergic, and cannabinoid) mechanisms, inflammatory pathways (IL-10, TNFα, GNβ...

full text

My Resources

Save resource for easier access later

Save to my library Already added to my library

{@ msg_add @}


Journal title

volume 10  issue 37

pages  34- 43

publication date 2023-03

By following a journal you will be notified via email when a new issue of this journal is published.

Keywords

No Keywords

Hosted on Doprax cloud platform doprax.com

copyright © 2015-2023